Sulfonylureas act by increasing insulin release from the beta cells in the pancreas. This causes your body to make more insulin. It also serves to “wear out” the beta cells of the pancreas. These drugs include:

• Glimepiride (Amaryl)
• Glimepiride-pioglitazone (Duetact)
• Glimeperide-rosiglitazone (Avandaryl)
• Gliclazide
• Glipizide (Glucotrol)
• Glipizide-metformin (Metaglip)
• Glyburide (DiaBeta, Glynase, Micronase)
• Glyburide-metformin (Glucovance)
• Chlorpropamide (Diabinese)
• Tolazamide (Tolinase)
• Tolbutamide (Orinase, Tol-Tab)

References:

Diabetes Medicine: Sulfonylureas
https://www.diabetesselfmanagement.com/blog/diabetes-medicine-sulfonylureas/

List of Sulfonylureas
https://www.drugs.com/drug-class/sulfonylureas.html

Most Sulfonylurea Drugs are Associated with Cardiac Risk
https://www.bloodsugar101.com/drugs-that-stimulate-insulin-secret

Stop Using Sulfonylureas?
Source [Not Secure] www-dot-diabetesincontrol-dot-com/stop-using-sulfonylureas/

---

Classes of Medications

• Alpha-glucosidase inhibitors
• Biguanides (metformin)
• Dopamine agonist (Cycloset)
• DPP-4 inhibitors (gliptins) (Januvia, Onglyza)
• GLP-1 (glucagon-like peptides) (Trulicity, Victoza)
• Insulin
• Meglitinides
• Sodium glucose transporter (SGLT-2 Inhibitors) (Farxiga, Invokana, Jardiance)
• Sulfonylureas (glipizide, glyburide)
• Thiazolidinediones (Avandia, Actos)